Streetbeat News

Analyst Ratings

HD

RBC Capital analyst Steven Shemesh has maintained a 'Sector Perform' rating on Home Depot (NYSE:HD) but reduced the price target from $303 to $299.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:54 pm

CAMT

Needham analyst Charles Shi has reaffirmed a Buy rating on Camtek (NASDAQ:CAMT) and increased the price target from $70 to $73.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:54 pm

CI

RBC Capital analyst Ben Hendrix has reiterated a 'Sector Perform' rating on Cigna Group (NYSE:CI) and maintained a price target of $327. This reaffirmation of the company's stock rating and price target suggests that RBC Capital views Cigna's stock as fairly valued at its current levels and expects it to perform in line with the sector.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:52 pm

CRMD

Needham analyst Serge Belanger has maintained a Buy rating on Cormedix (NASDAQ:CRMD) but has reduced the price target from $12 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:52 pm

FHN

RBC Capital analyst Jon Arfstrom has maintained a 'Sector Perform' rating on First Horizon (NYSE:FHN) and increased the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:50 pm

DVN

RBC Capital analyst Scott Hanold has maintained a 'Sector Perform' rating on Devon Energy (NYSE:DVN) but lowered the price target from $60 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:49 pm

ACLX

HC Wainwright & Co. analyst Emily Bodnar has reaffirmed a Buy rating on Arcellx (NASDAQ:ACLX) and increased the price target from $50 to $60, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:48 pm

CRMD

RBC Capital analyst Gregory Renza has maintained an Outperform rating on Cormedix (NASDAQ:CRMD) and increased the price target from $6 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:47 pm

CRMD

Truist Securities analyst Joon Lee has reiterated a Buy rating on Cormedix (NASDAQ:CRMD) and maintained the price target of $18 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:46 pm

ACM

RBC Capital analyst Arthur Nagorny has maintained an Outperform rating on AECOM (NYSE:ACM) and increased the price target from $102 to $109.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:45 pm